| Not Yet Recruiting | MucoLock™ for Treatment of Stomatitis NCT07506018 | Baptist Health South Florida | N/A |
| Not Yet Recruiting | An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in El NCT07357597 | AstraZeneca | Phase 4 |
| Recruiting | Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients NCT07400328 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Recruiting | Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy f NCT06532279 | NRG Oncology | Phase 2 |
| Recruiting | Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogene NCT06071637 | Instituto Nacional de Cancer, Brazil | Phase 3 |
| Completed | Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer NCT05878405 | Mayo Clinic | Phase 3 |
| Unknown | The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiot NCT05323058 | Cairo University | Phase 2 |
| Unknown | Using Tea-based Mouthwash Relieve Stomatitis and Oral Ulcers NCT05010928 | Chang Gung Memorial Hospital | Phase 2 |
| Completed | MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN) NCT03469284 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Non-Thermal Plasma vs. Low-Level Laser Therapy for Recurrent Oral Ulcers NCT07322666 | National Institute of Nuclear Research - Mexico | N/A |
| Unknown | Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis NCT03778008 | Second Affiliated Hospital of Nanchang University | Phase 2 |
| Completed | EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation NCT03200340 | Enzychem Lifesciences Corporation | Phase 2 |
| Recruiting | Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma NCT03581773 | Niels Fristrup | Phase 2 |
| Unknown | Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Car NCT02945878 | Zhejiang Cancer Hospital | — |
| Unknown | Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharynge NCT02735317 | Yun-fei Xia | Phase 2 |
| Completed | Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With NCT02531906 | Roswell Park Cancer Institute | Phase 1 |
| Terminated | Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant NCT02326675 | University of Florida | N/A |
| Completed | Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus NCT02229136 | US Oncology Research | Phase 2 |
| Completed | Laser for Oral Mucositis in Pediatric Onco-hematology NCT02762019 | IRCCS Burlo Garofolo | Phase 3 |
| Completed | Effectiveness of Hygiene Solutions on Denture Biofilm NCT02407834 | University of Sao Paulo | Phase 4 |
| Completed | Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer NCT01837446 | Isfahan University of Medical Sciences | Phase 2 / Phase 3 |
| Terminated | Safety of Phenylephrine for Oral Mucositis Prevention NCT01092975 | University of Wisconsin, Madison | Phase 1 |
| Unknown | The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patient NCT01099891 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Completed | Efficacy of SNX-1012 in the Treatment of Oral Mucositis NCT00385515 | Mucosal Therapeutics | Phase 2 |
| Completed | A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis NCT00323518 | CuraGen Corporation | Phase 2 |
| Completed | Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer NCT00101582 | Swedish Orphan Biovitrum | Phase 3 |
| Completed | Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transp NCT00104065 | CuraGen Corporation | Phase 2 |
| Terminated | Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis NCT00075023 | National Institute of Nursing Research (NINR) | Phase 2 |
| Terminated | Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Inj NCT00031551 | National Institute of Nursing Research (NINR) | Phase 2 |
| Completed | A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of O NCT00001812 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting NCT00051441 | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Phase 3 |
| Completed | Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Under NCT00041665 | Amgen | Phase 3 |
| Withdrawn | Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine NCT01288625 | Sun Pharmaceutical Industries Limited | Phase 4 |